TUNAR
gene geneOn this page
Also known as BNLNTUNApTUNARHI-LNC78
Summary
TUNAR (transmembrane neural differentiation associated intracellular calcium regulator, HGNC:44088) is a protein-coding gene on chromosome 14q32.2, encoding Protein TUNAR (A0A1B0GTB2). In neurons, plays a role in the regulation of intracellular Ca(2+), possibly by acting as an activator of ATP2A2/SERCA2, thus increasing the efficiency with which Ca(2+) is removed from the cytoplasm.
Enables ATPase binding activity. Involved in endoplasmic reticulum calcium ion homeostasis and positive regulation of insulin secretion involved in cellular response to glucose stimulus. Located in endoplasmic reticulum.
Source: NCBI Gene 100507043 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001416131
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44088 |
| Approved symbol | TUNAR |
| Name | transmembrane neural differentiation associated intracellular calcium regulator |
| Location | 14q32.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | BNLN, TUNA, pTUNAR, HI-LNC78 |
| Ensembl gene | ENSG00000250366 |
| Ensembl biotype | protein_coding |
| OMIM | 615719 |
| Entrez | 100507043 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000503525, ENST00000504119, ENST00000554321, ENST00000678517, ENST00000687554, ENST00000917015
RefSeq mRNA: 3 — MANE Select: NM_001416131
NM_001416131, NM_001416132, NM_001416133
Canonical transcript exons
ENST00000503525 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002466009 | 95876832 | 95877177 |
| ENSE00002519913 | 95922781 | 95925571 |
Expression profiles
Bgee: expression breadth ubiquitous, 116 present calls, max score 93.03.
FANTOM5 (CAGE): breadth broad, TPM avg 3.1858 / max 186.7662, expressed in 290 samples.
FANTOM5 promoters (17 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 141321 | 1.0257 | 175 |
| 141309 | 0.3490 | 142 |
| 141308 | 0.2782 | 132 |
| 141323 | 0.2650 | 120 |
| 141314 | 0.2353 | 90 |
| 141313 | 0.1967 | 100 |
| 141322 | 0.1858 | 94 |
| 141315 | 0.1319 | 78 |
| 141310 | 0.1196 | 61 |
| 141311 | 0.1016 | 66 |
Top tissues by expression
230 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| putamen | UBERON:0001874 | 93.03 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 92.02 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.97 | gold quality |
| caudate nucleus | UBERON:0001873 | 91.95 | gold quality |
| pons | UBERON:0000988 | 90.78 | gold quality |
| nucleus accumbens | UBERON:0001882 | 87.45 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 86.37 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 82.51 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.32 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.29 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 81.79 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.58 | gold quality |
| hypothalamus | UBERON:0001898 | 81.34 | gold quality |
| frontal cortex | UBERON:0001870 | 80.95 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 80.41 | gold quality |
| neocortex | UBERON:0001950 | 80.35 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.54 | gold quality |
| cerebral cortex | UBERON:0000956 | 79.47 | gold quality |
| forebrain | UBERON:0001890 | 79.42 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 78.23 | gold quality |
| Ammon’s horn | UBERON:0001954 | 77.73 | gold quality |
| brain | UBERON:0000955 | 77.68 | gold quality |
| entorhinal cortex | UBERON:0002728 | 75.25 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 74.83 | silver quality |
| cortical plate | UBERON:0005343 | 74.81 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 74.67 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 74.14 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 73.99 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 73.70 | gold quality |
| medulla oblongata | UBERON:0001896 | 72.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.27 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- This study found the human ortholog of TUNA, linc00617, was upregulated in breast cancer samples. (PMID:26207516)
- The long noncoding RNA TUNAR modulates Wnt signaling and regulates human beta-cell proliferation. (PMID:33682459)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tunar | ENSMUSG00000097929 |
| rattus_norvegicus | ENSRNOG00000083299 |
Protein
Protein identifiers
Protein TUNAR — A0A1B0GTB2 (reviewed: A0A1B0GTB2)
Alternative names: Beta cell and neural cell-regulin, TCL1 upstream neural differentiation-associated RNA
All UniProt accessions (2): A0A1B0GTB2, A0A7I2V4K3
UniProt curated annotations — full annotation on UniProt →
Function. In neurons, plays a role in the regulation of intracellular Ca(2+), possibly by acting as an activator of ATP2A2/SERCA2, thus increasing the efficiency with which Ca(2+) is removed from the cytoplasm. Inhibits differentiation of embryonic stem cells into neurons and inhibits neurite outgrowth, likely as a result of its role in intracellular Ca(2+) regulation. In pancreatic beta cells, lowers Ca(2+) levels in the endoplasmic reticulum and enhances glucose-stimulated insulin secretion.
Subunit / interactions. Interacts with ATPase ATP2A2/SERCA2. Interacts with ATPase ATP2A3/SERCA3; the interaction occurs at low levels in low glucose conditions and is increased by high glucose levels.
Subcellular location. Endoplasmic reticulum membrane. Extracellular vesicle membrane.
Tissue specificity. Highly expressed in pancreatic islets where it is enriched in the insulin-producing beta cells.
RefSeq proteins (3): NP_001403060, NP_001403061, NP_001403062 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR054138 | TUNAR | Family |
Pfam: PF21954
UniProt features (4 total): chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GTB2-F1 | 82.22 | 0.52 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 79 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_INSULIN_SECRETION, GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS, GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_HORMONE_TRANSPORT, GOBP_NEUROGENESIS, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_CELL_CELL_SIGNALING, GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION, GOBP_REGULATION_OF_PROTEIN_SECRETION, GOBP_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_REGULATION_OF_CELLULAR_LOCALIZATION, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND
GO Biological Process (6): endoplasmic reticulum calcium ion homeostasis (GO:0032469), positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774), negative regulation of neuron differentiation (GO:0045665), neuron projection morphogenesis (GO:0048812), regulation of cytosolic calcium ion concentration (GO:0051480), nervous system development (GO:0007399)
GO Molecular Function (1): ATPase binding (GO:0051117)
GO Cellular Component (3): endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular calcium ion homeostasis | 2 |
| endoplasmic reticulum | 1 |
| positive regulation of insulin secretion | 1 |
| insulin secretion involved in cellular response to glucose stimulus | 1 |
| regulation of insulin secretion involved in cellular response to glucose stimulus | 1 |
| neuron differentiation | 1 |
| negative regulation of cell differentiation | 1 |
| regulation of neuron differentiation | 1 |
| neuron projection development | 1 |
| plasma membrane bounded cell projection morphogenesis | 1 |
| system development | 1 |
| enzyme binding | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
68 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TUNAR | PTBP1 | P26599 | 578 |
| TUNAR | HNRNPK | P61978 | 549 |
| TUNAR | TMEM150C | B9EJG8 | 372 |
| TUNAR | DLX6 | P56179 | 293 |
| TUNAR | ACAA1 | P09110 | 285 |
| TUNAR | FAM91A1 | Q658Y4 | 279 |
| TUNAR | SOX2 | P48431 | 244 |
| TUNAR | NANOG | Q9H9S0 | 220 |
| TUNAR | POU3F3 | P20264 | 216 |
| TUNAR | MAPK4 | P31152 | 216 |
| TUNAR | DLX1 | P56177 | 215 |
| TUNAR | PRR32 | B1ATL7 | 210 |
| TUNAR | PMEPA1 | Q969W9 | 205 |
| TUNAR | WEE2 | P0C1S8 | 204 |
| TUNAR | DISC1 | Q9NRI5 | 202 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GQX2, A0A1B0GTB2, A2BUT0, A2C0D2, A6BM34, A7M911, A8W3J7, B0JYB0, B1WS50, B2J4U1, B2Y1W9, B7JV08, B7KFH4, O19926, O29047, O70901, P0C0X9, P0C179, P0DI80, P27387, P29662, P30395, P31591, P58246, Q06GN1, Q06RE7, Q06SD5, Q06SI9, Q110N3, Q1ACL7, Q28053, Q28280, Q28748, Q28757, Q29149, Q32FX5, Q3J1A4, Q3M5W2, Q46H80, Q54YR4
Diamond homologs: A0A1B0GQX2, A0A1B0GTB2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000027710 (14:95878928 A>G), RS1000049082 (14:95899717 G>C), RS1000099223 (14:95900777 G>A,T), RS1000113105 (14:95874783 G>A), RS1000187775 (14:95912372 C>T), RS1000195764 (14:95912276 T>C), RS1000213838 (14:95889004 G>A), RS1000352354 (14:95883584 C>G,T), RS1000488134 (14:95883352 A>G,T), RS1000519215 (14:95884711 C>A), RS1000623426 (14:95879313 A>G), RS1000626865 (14:95877472 G>A), RS1000705113 (14:95890104 T>C), RS1000712468 (14:95888820 T>C), RS1000741217 (14:95904997 G>A,C)
Disease associations
OMIM: gene MIM:615719 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002945_22 | Emphysema imaging phenotypes | 2.000000e-06 |
| GCST002945_39 | Emphysema imaging phenotypes | 4.000000e-07 |
| GCST008892_15 | Working memory | 3.000000e-06 |
| GCST009066_41 | Mosaic loss of chromosome Y (Y chromosome dosage) | 4.000000e-18 |
| GCST009067_32 | Mosaic loss of chromosome Y (Y chromosome dosage) | 2.000000e-106 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007626 | emphysema imaging measurement |
| EFO:0004335 | short-term memory |
| EFO:0007783 | mosaic loss of chromosome Y measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Phenylmercuric Acetate | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.